ouabain has been researched along with granisetron in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Blower, PR; Endo, T; Minami, M; Nemoto, M; Sugawara, J | 1 |
| Behnam-Motlagh, P; Grankvist, K; Henriksson, R; Sandström, PE | 1 |
3 other study(ies) available for ouabain and granisetron
| Article | Year |
|---|---|
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Effects of granisetron, a selective 5-HT3 receptor antagonist, on ouabain-induced emesis in ferrets.
Topics: Abdomen; Animals; Antiemetics; Dose-Response Relationship, Drug; Ferrets; Granisetron; Ileum; In Vitro Techniques; Male; Neurons, Afferent; Ouabain; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists; Vagus Nerve; Vomiting | 1998 |
Diverging effects of 5-HT3 receptor antagonists ondansetron and granisetron on estramustine-inhibited cellular potassium transport.
Topics: Antiemetics; Antineoplastic Agents; Biological Transport; Bumetanide; Chlorides; Drug Interactions; Estramustine; Granisetron; Humans; K Cl- Cotransporters; Lung Neoplasms; Mesothelioma; Ondansetron; Ouabain; Potassium; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Sodium; Sodium-Potassium-Exchanging ATPase; Symporters; Time Factors; Tumor Cells, Cultured | 2001 |